80 related articles for article (PubMed ID: 35153452)
1. Assessment of activity of chalcone compounds as inhibitors of 3-chymotrypsin like protease (3CL
Mathpal S; Joshi T; Sharma P; Pande V; Chandra S
Struct Chem; 2022; 33(5):1815-1831. PubMed ID: 35153452
[TBL] [Abstract][Full Text] [Related]
2. Exploration of chalcones as 3-chymotrypsin-like protease (3CL
Lam TP; Nguyen DN; Mai TT; Tran TD; Le MT; Huynh PNH; Nguyen DT; Tran VH; Trinh DT; Truong P; Vo CT; Thai KM
Struct Chem; 2022; 33(5):1707-1725. PubMed ID: 35811783
[TBL] [Abstract][Full Text] [Related]
3. Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation.
Elekofehinti OO; Iwaloye O; Molehin OR; Famusiwa CD
In Silico Pharmacol; 2021; 9(1):49. PubMed ID: 34395160
[TBL] [Abstract][Full Text] [Related]
4. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2
Khan SA; Zia K; Ashraf S; Uddin R; Ul-Haq Z
J Biomol Struct Dyn; 2021 Apr; 39(7):2607-2616. PubMed ID: 32238094
[TBL] [Abstract][Full Text] [Related]
5. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL
Gyebi GA; Ogunro OB; Adegunloye AP; Ogunyemi OM; Afolabi SO
J Biomol Struct Dyn; 2021 Jun; 39(9):3396-3408. PubMed ID: 32367767
[TBL] [Abstract][Full Text] [Related]
6. In silico screening of chalcone derivatives as promising EGFR-TK inhibitors for the clinical treatment of cancer.
Mathpal S; Joshi T; Sharma P; Maiti P; Nand M; Pande V; Chandra S
3 Biotech; 2024 Jan; 14(1):18. PubMed ID: 38130684
[TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening of novel natural products as chalcone derivatives against SARS-CoV-2 M
El Aissouq A; Bouachrine M; Bouayyadi L; Ouammou A; Khalil F
J Biomol Struct Dyn; 2023; 41(22):13235-13249. PubMed ID: 36752320
[TBL] [Abstract][Full Text] [Related]
8. Antiviral phytocompounds "ellagic acid" and "(+)-sesamin" of
Umar AK; Zothantluanga JH; Aswin K; Maulana S; Sulaiman Zubair M; Lalhlenmawia H; Rudrapal M; Chetia D
Struct Chem; 2022; 33(5):1445-1465. PubMed ID: 35571865
[TBL] [Abstract][Full Text] [Related]
9. Study on the mechanism of active components of Liupao tea on 3CL
Ni WJ; Chen XX; Wei SY; Lan LL; Qiu RJ; Ling YP; Zhou DS; Wu ZM; Cao ZH; Yu CP; Zeng Y
J Food Biochem; 2021 May; 45(5):e13707. PubMed ID: 33760271
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.
Bepari AK; Reza HM
PeerJ; 2021; 9():e11261. PubMed ID: 33954055
[TBL] [Abstract][Full Text] [Related]
11.
Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
[TBL] [Abstract][Full Text] [Related]
12.
Mujwar S; Harwansh RK
Struct Chem; 2022; 33(5):1517-1528. PubMed ID: 35502321
[TBL] [Abstract][Full Text] [Related]
13.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
14. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
15. In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme.
Chatterjee S; Maity A; Chowdhury S; Islam MA; Muttinini RK; Sen D
J Biomol Struct Dyn; 2021 Sep; 39(14):5290-5303. PubMed ID: 32608329
[TBL] [Abstract][Full Text] [Related]
16. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2.
Vijayakumar BG; Ramesh D; Joji A; Jayachandra Prakasan J; Kannan T
Eur J Pharmacol; 2020 Nov; 886():173448. PubMed ID: 32768503
[TBL] [Abstract][Full Text] [Related]
17.
Maulana S; Wahyuni TS; Widiyanti P; Zubair MS
J Public Health Afr; 2023 Mar; 14(Suppl 1):2508. PubMed ID: 37492544
[TBL] [Abstract][Full Text] [Related]
18. Integrated computational approach towards repurposing of antimalarial drug against SARS-CoV-2 main protease.
Gogoi N; Chowdhury P; Goswami AK; Das A; Chetia D; Gogoi B
Struct Chem; 2022; 33(5):1409-1422. PubMed ID: 35669793
[TBL] [Abstract][Full Text] [Related]
19. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease.
Joshi T; Joshi T; Pundir H; Sharma P; Mathpal S; Chandra S
J Biomol Struct Dyn; 2021 Oct; 39(17):6728-6746. PubMed ID: 32752947
[TBL] [Abstract][Full Text] [Related]
20. Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CL
Daoui O; Elkhattabi S; Chtita S
Struct Chem; 2022; 33(5):1667-1690. PubMed ID: 35818588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]